Abstract
We report a rash after the first dose of antituberculosis polytherapy which raises questions concerning procedures to be followed.
Case report:
An 8-year-old child presented with a pruritic rash 1.5 hours after the first dose of isoniazide, rifampicine, pyrazinamide and ethambutol was simultaneously administered, which did not recur after successive re-administration of isoniazide and rifampicine. Pyrazinamide, which was re-administered last, induced a recurrence. Slower pyrazinamide re-administration allowed continuation of treatment.
Conclusion:
A protocol for re-administration of the four drugs is suggested.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antibiotics, Antitubercular / administration & dosage
-
Antibiotics, Antitubercular / therapeutic use
-
Antitubercular Agents / administration & dosage
-
Antitubercular Agents / adverse effects*
-
Child
-
Drug Combinations
-
Drug Eruptions / etiology*
-
Ethambutol / administration & dosage
-
Ethambutol / therapeutic use
-
Exanthema / chemically induced*
-
Humans
-
Isoniazid / administration & dosage
-
Isoniazid / therapeutic use
-
Male
-
Pyrazinamide / administration & dosage
-
Pyrazinamide / adverse effects*
-
Recurrence
-
Rifampin / administration & dosage
-
Rifampin / therapeutic use
-
Tuberculosis, Pulmonary / drug therapy*
Substances
-
Antibiotics, Antitubercular
-
Antitubercular Agents
-
Drug Combinations
-
Pyrazinamide
-
Ethambutol
-
Isoniazid
-
Rifampin